Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • PI3K
    (3)
  • mTOR
    (3)
  • Others
    (2)
TargetMol | Tags By ResearchField
  • Cancer
    (3)
Filter
Search Result
Results for "

gedatolisib

" in TargetMol Product Catalog.
  • Inhibitors & Agonists
    3
    TargetMol | All_Pathways
  • Gedatolisib
    PKI-587, PF-05212384
    T19701197160-78-3
    Gedatolisib (PF-05212384) is a highly effective dual inhibitor targeting the PI3Kα/γ (IC50: 0.4/5.4 nM)and mTOR (IC50: 1.6 nM) in the PI3K/mTOR signaling pathway.
    • $45
    In Stock
    Size
    QTY
  • PI3K/mTOR Inhibitor-7
    T640412456295-65-9
    PI3K/mTOR Inhibitor-7 is a potent dual PI3K/mTOR inhibitor. PI3K/mTOR Inhibitor-7 is 4.7-fold more potent than gedatolisib, with IC50 values of 1.4 μM and 0.3 μM, respectively. 10 μM of PI3K/mTOR Inhibitor-7 is able to significantly inhibit the PI3K/Akt/mTOR signalling pathway. PI3K/mTOR Inhibitor-7 has shown potential for research in cancer diseases.
    • $1,520
    8-10 weeks
    Size
    QTY
  • PI3K/mTOR Inhibitor-6
    T642192456295-59-1
    PI3K/mTOR Inhibitor-6 (Compound 19c) is a potent dual PI3K/mTOR inhibitor, exhibiting greater stability than gedatolisib in artificial gastric fluid. At 10 μM, PI3K/mTOR Inhibitor-6 significantly inhibits the PI3K/Akt/mTOR signaling pathway and has shown potential for cancer research.
    • $1,520
    8-10 weeks
    Size
    QTY